HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,525 | -56.3% | 9,192 | -44.2% | 0.00% | – |
| Q2 2023 | $90,431 | +8407.1% | 16,472 | +6410.7% | 0.00% | – |
| Q1 2023 | $1,063 | -92.7% | 253 | -95.2% | 0.00% | – |
| Q4 2022 | $14,543 | +1354.3% | 5,250 | +2060.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 243 | -1.2% | 0.00% | – |
| Q2 2022 | $1,000 | -99.6% | 246 | -99.4% | 0.00% | – |
| Q1 2022 | $272,000 | -77.8% | 43,872 | -74.8% | 0.00% | – |
| Q4 2021 | $1,226,000 | -58.4% | 173,892 | -58.8% | 0.00% | -100.0% |
| Q3 2021 | $2,949,000 | -16.3% | 422,499 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $3,525,000 | +161.3% | 423,186 | +71.4% | 0.00% | – |
| Q1 2021 | $1,349,000 | +446.2% | 246,933 | +328.2% | 0.00% | – |
| Q4 2020 | $247,000 | -20.8% | 57,665 | -44.3% | 0.00% | – |
| Q3 2020 | $312,000 | +51.5% | 103,585 | +56.5% | 0.00% | – |
| Q2 2020 | $206,000 | +85.6% | 66,189 | +31.1% | 0.00% | – |
| Q1 2020 | $111,000 | -20.1% | 50,480 | +10.6% | 0.00% | – |
| Q4 2019 | $139,000 | -11.5% | 45,653 | -10.3% | 0.00% | – |
| Q3 2019 | $157,000 | +17.2% | 50,885 | -23.6% | 0.00% | – |
| Q2 2019 | $134,000 | -63.1% | 66,620 | -21.0% | 0.00% | – |
| Q1 2019 | $363,000 | +102.8% | 84,285 | +50.1% | 0.00% | – |
| Q4 2018 | $179,000 | -11.8% | 56,149 | +45.1% | 0.00% | – |
| Q3 2018 | $203,000 | +3.6% | 38,686 | +5.6% | 0.00% | – |
| Q2 2018 | $196,000 | +8.9% | 36,641 | +2.1% | 0.00% | – |
| Q1 2018 | $180,000 | +68.2% | 35,871 | +10.6% | 0.00% | – |
| Q4 2017 | $107,000 | +1683.3% | 32,446 | +2013.7% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 1,535 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -55.6% | 1,535 | -56.6% | 0.00% | – |
| Q1 2017 | $9,000 | -18.2% | 3,535 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | +120.0% | 3,535 | +76.8% | 0.00% | – |
| Q3 2016 | $5,000 | -84.8% | 2,000 | -81.6% | 0.00% | – |
| Q1 2016 | $33,000 | -5.7% | 10,841 | +9.0% | 0.00% | – |
| Q4 2015 | $35,000 | +45.8% | 9,944 | +56.1% | 0.00% | – |
| Q3 2015 | $24,000 | -94.9% | 6,369 | -92.3% | 0.00% | – |
| Q2 2015 | $472,000 | +34.9% | 82,845 | +37.9% | 0.00% | – |
| Q1 2015 | $350,000 | +81.3% | 60,080 | +76.4% | 0.00% | – |
| Q4 2014 | $193,000 | +672.0% | 34,060 | +467.7% | 0.00% | – |
| Q3 2014 | $25,000 | -7.4% | 6,000 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | -3.6% | 6,000 | 0.0% | 0.00% | – |
| Q1 2014 | $28,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2013 | $28,000 | -39.1% | 6,000 | -31.2% | 0.00% | – |
| Q3 2013 | $46,000 | +27.8% | 8,718 | +13.0% | 0.00% | – |
| Q2 2013 | $36,000 | – | 7,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |